Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Ixazomib has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of relapsed or refractory multiple myeloma.Precautions for the Administration of Ixazomi···【more】
Article source：Captain MedicineRelease date：2026-01-08Recommended：376
Ixazomib is available in capsule dosage form and is a prescription-only medicine, which must be purchased with a doctor’s prescription.Precautions for IxazomibDuring treatment with···【more】
Article source：Captain MedicineRelease date：2026-01-08Recommended：385
Ixazomib is classified as an antineoplastic agent (anticancer drug). Its mechanism of action involves interfering with the growth of cancer cells and ultimately enabling the body t···【more】
Article source：Captain MedicineRelease date：2026-01-07Recommended：284
Ixazomib, in combination with lenalidomide and dexamethasone, is indicated for the treatment of patients with multiple myeloma who have received at least one prior line of therapy.···【more】
Article source：Captain MedicineRelease date：2026-01-07Recommended：285
Ixazomib is a proteasome inhibitor drug. Its mechanism of action is to prevent multiple myeloma cells from breaking down proteins, leading to the accumulation of intracellular prot···【more】
Article source：Captain MedicineRelease date：2026-01-07Recommended：316
Ixazomib is typically indicated for the treatment of multiple myeloma, a type of blood cancer. On the basis of a physician’s clinical judgment, ixazomib may also be used for other ···【more】
Article source：Captain MedicineRelease date：2026-01-07Recommended：323
Ixazomib is indicated for the treatment of multiple myeloma. Its mechanism of action involves blocking a protein that promotes the growth and proliferation of cancer cells, thereby···【more】
Article source：Captain MedicineRelease date：2026-01-07Recommended：330
Ixazomib is a medication indicated for the treatment of multiple myeloma, exerting its therapeutic effect by inhibiting the growth of cancer cells. This malignancy may affect the b···【more】
Article source：Captain MedicineRelease date：2026-01-07Recommended：280
Ixazomib is indicated for the treatment of multiple myeloma, a type of bone marrow cancer. Its mechanism of action involves inhibiting a protein that drives the growth and prolifer···【more】
Article source：Captain MedicineRelease date：2026-01-07Recommended：306
Ixazomib is a second-generation proteasome inhibitor that has emerged as a pivotal therapeutic option for the treatment of multiple myeloma.What are the indications of Ixazomib?Ixa···【more】
Article source：Captain MedicineRelease date：2026-01-07Recommended：308
Ixazomib is a targeted, reversible proteasome inhibitor that has been approved for use in combination with lenalidomide and dexamethasone for the treatment of relapsed multiple mye···【more】
Article source：Captain MedicineRelease date：2026-01-07Recommended：355
Ixazomib is part of an all-oral treatment regimen. When used in combination with lenalidomide and dexamethasone, it provides a convenient treatment option for patients with multipl···【more】
Article source：Captain MedicineRelease date：2026-01-07Recommended：348
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：8552025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：10562024-09-07
Recently, Lao Lucius Pharmaceutical (Lucius Pharmaceuticals) issued a solemn statement regarding cou···【more】
Recommended：3482026-10-10
Lucius Pharmaceuticals Version of Vibegron Now Available1.Basic Drug InformationVibegron (generic na···【more】
Recommended：4212026-06-08
In recent years, leveraging the World Trade Organization (WTO) patent waiver for least-developed cou···【more】
Recommended：6212026-05-08
How Can Chinese Patients Access Generic Drugs from Laos?In recent years, generic drugs from Laos hav···【more】
Recommended：6072026-04-08
Lucius Pharmaceuticals version of Ibrutinib is now availableIn a randomized controlled trial of 269 ···【more】
Recommended：4762026-03-08
Leveraging the WTO patent waiver for least-developed countries (extended to 2033), Laos has seen rap···【more】
Recommended：6232026-31-07
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
